InsiderClue
Insiders · Profile

BVF PARTNERS L P/IL

Director at Kymera Therapeutics · Director at MoonLake Immunotherapeutics · 10% owner at Eledon Pharmaceuticals · and 15 more. Filing since 21 Feb 2008. CIK 0001055947

KYMR Kymera Therapeutics, Inc. Director · 17 trades MLTX MoonLake Immunotherapeutics Director · 2 trades ELDN Eledon Pharmaceuticals, Inc. 10% owner · 2 trades OLMA Olema Pharmaceuticals, Inc. Director · 4 trades CGEM Cullinan Therapeutics, Inc. 10% owner · 4 trades IDYA IDEAYA Biosciences, Inc. See Explanation of Responses · 4 trades CYTK CYTOKINETICS INC See Explanaton of Responses · 4 trades CBIO CRESCENT BIOPHARMA, INC. 10% owner · 3 trades PVLA PALVELLA THERAPEUTICS, INC. 10% owner · 1 trade XENE Xenon Pharmaceuticals Inc. 10% owner · 10 trades CAPS Capstone Holding Corp. See Explanation of Responses · 20 trades LGND LIGAND PHARMACEUTICALS INC See Explanation of Responses · 69 trades PTN PALATIN TECHNOLOGIES INC 10% owner · 19 trades RIGL RIGEL PHARMACEUTICALS INC 10% owner · 2 trades GYRE GYRE THERAPEUTICS, INC. 10% owner · 13 trades NBIX NEUROCRINE BIOSCIENCES INC 10% owner · 48 trades RGEN REPLIGEN CORP 10% owner · 2 trades CRIS CURIS INC 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
KYMR Kymera Therapeutics, Inc.
26 Jun 2026
Director
Sold at will
1,578,800
$168.14M
86.8%
KYMR Kymera Therapeutics, Inc.
26 Jun 2026
Director
Sold at will
51,858
$5.52M
39.7%
MLTX MoonLake Immunotherapeutics
31 Mar 2026
Director
Sold at will
3,750,000
$62.96M
78.3%
KYMR Kymera Therapeutics, Inc.
30 Jun 2025
Director
Bought
317,167
$13.96M
12.8%
MLTX MoonLake Immunotherapeutics
4 Oct 2024
Director
Sold at will
2,000,000
$100.00M
60.8%
ELDN Eledon Pharmaceuticals, Inc.
9 May 2024
10% owner
Bought
1,927,937
no price
134%
KYMR Kymera Therapeutics, Inc.
3 Nov 2023
Director
Bought
197,699
$2.78M
8.0%
KYMR Kymera Therapeutics, Inc.
2 Nov 2023
Director
Bought
216,406
$2.52M
9.3%
OLMA Olema Pharmaceuticals, Inc.
12 Sep 2023
Director
Bought
1,505,932
$14.82M
47.3%
ELDN Eledon Pharmaceuticals, Inc.
5 May 2023
10% owner
Bought
1,978,932
no price
563%
KYMR Kymera Therapeutics, Inc.
12 Jan 2023
Director
Bought
18,897
$590.39K
0.8%
KYMR Kymera Therapeutics, Inc.
11 Jan 2023
Director
Bought
22,110
$660.80K
0.9%
KYMR Kymera Therapeutics, Inc.
22 Aug 2022
Director
Bought
545,525
$14.18M
28.2%
OLMA Olema Pharmaceuticals, Inc.
10 Jun 2022
Director
Bought
200,000
$806.90K
5.4%
CGEM Cullinan Therapeutics, Inc.
1 Jun 2022
10% owner
Bought
751,396
$8.26M
22.7%
KYMR Kymera Therapeutics, Inc.
27 May 2022
Director
Bought
65,369
$966.34K
3.1%
KYMR Kymera Therapeutics, Inc.
26 May 2022
Director
Bought
224,057
$3.18M
11.6%
KYMR Kymera Therapeutics, Inc.
20 May 2022
Director
Bought
10,100
$141.39K
0.5%
CGEM Cullinan Therapeutics, Inc.
13 May 2022
10% owner
Bought
109,900
$1.00M
3.1%
CGEM Cullinan Therapeutics, Inc.
12 May 2022
10% owner
Bought
1,000,000
$9.06M
38.5%
KYMR Kymera Therapeutics, Inc.
6 May 2022
Director
Bought
100,000
$1.93M
5.2%
KYMR Kymera Therapeutics, Inc.
5 May 2022
Director
Bought
150,000
$2.94M
8.2%
CGEM Cullinan Therapeutics, Inc.
1 Apr 2022
10% owner
Bought
276,000
$2.97M
9.9%
KYMR Kymera Therapeutics, Inc.
31 Jan 2022
Director
Bought
34,408
$1.40M
1.8%
KYMR Kymera Therapeutics, Inc.
27 Jan 2022
Director
Bought
95,901
$3.68M
5.4%
KYMR Kymera Therapeutics, Inc.
24 Jan 2022
Director
Bought
272,767
$10.30M
17.6%
OLMA Olema Pharmaceuticals, Inc.
30 Nov 2021
Director
Bought
739,675
$6.95M
24.5%
KYMR Kymera Therapeutics, Inc.
1 Jul 2021
Director
Bought
544,166
$25.58M
48.6%
IDYA IDEAYA Biosciences, Inc.
2 Feb 2021
See Explanation of Responses
Sold, plan not stated
46,409
$835.36K
16.6%
CYTK CYTOKINETICS INC
9 Dec 2020
See Explanaton of Responses
Sold, plan not stated
430,954
$7.76M
48.2%
OLMA Olema Pharmaceuticals, Inc.
19 Nov 2020
Director
Bought
1,135,334
$21.57M
50.3%
CBIO CRESCENT BIOPHARMA, INC.
4 Nov 2020
10% owner
Bought
1,266,737
$3.29M
34.1%
CBIO CRESCENT BIOPHARMA, INC.
30 Oct 2020
10% owner
Bought
932,612
$2.56M
27.6%
IDYA IDEAYA Biosciences, Inc.
30 Jun 2020
10% owner
Bought
2,531
$33.70K
0.2%
IDYA IDEAYA Biosciences, Inc.
22 Jun 2020
10% owner
Bought
19,732
$274.96K
1.2%
IDYA IDEAYA Biosciences, Inc.
19 Jun 2020
10% owner
Bought
98,264
$1.41M
6.3%
CYTK CYTOKINETICS INC
13 Feb 2020
10% owner
Sold, plan not stated
1,072,030
$16.92M
71.6%
CYTK CYTOKINETICS INC
11 Dec 2019
10% owner
Bought
118,413
$1.13M
3.4%
CYTK CYTOKINETICS INC
10 Dec 2019
10% owner
Bought
223,659
$2.10M
6.7%
PVLA PALVELLA THERAPEUTICS, INC.
6 Sep 2019
10% owner
Sold, plan not stated
50,000
$224.97K
13.7%
CBIO CRESCENT BIOPHARMA, INC.
5 Sep 2019
10% owner
Bought
1,668,746
$5.31M
84.7%
XENE Xenon Pharmaceuticals Inc.
15 Aug 2017
10% owner
Bought
18,858
$45.49K
1.1%
XENE Xenon Pharmaceuticals Inc.
14 Aug 2017
10% owner
Bought
41,344
$111.78K
2.5%
CAPS Capstone Holding Corp.
14 Jul 2017
See Explanation of Responses
Sold, plan not stated
3,993,637
$239.62K
100%
CAPS Capstone Holding Corp.
14 Jul 2017
See Explanation of Responses
Sold, plan not stated
242,236
$14.53K
15.0%
CAPS Capstone Holding Corp.
14 Jul 2017
See Explanation of Responses
Sold, plan not stated
105,713
$6.34K
10.6%
XENE Xenon Pharmaceuticals Inc.
27 Jun 2017
10% owner
Bought
85,461
$341.84K
5.5%
XENE Xenon Pharmaceuticals Inc.
22 Jun 2017
10% owner
Bought
8,263
$33.05K
0.5%
XENE Xenon Pharmaceuticals Inc.
21 Jun 2017
10% owner
Bought
12,148
$48.59K
0.8%
XENE Xenon Pharmaceuticals Inc.
19 Jun 2017
10% owner
Bought
3,595
$13.84K
0.2%
XENE Xenon Pharmaceuticals Inc.
16 Jun 2017
10% owner
Bought
11,034
$42.48K
0.7%
XENE Xenon Pharmaceuticals Inc.
15 Jun 2017
10% owner
Bought
11,779
$45.20K
0.8%
XENE Xenon Pharmaceuticals Inc.
7 Jun 2017
10% owner
Bought
207,789
$800.24K
15.3%
XENE Xenon Pharmaceuticals Inc.
6 Jun 2017
10% owner
Bought
150,909
$565.91K
11.6%
LGND LIGAND PHARMACEUTICALS INC
25 Mar 2014
See Explanation of Responses
Sold, plan not stated
18,019
$1.26M
7.3%
LGND LIGAND PHARMACEUTICALS INC
25 Mar 2014
See Explanation of Responses
Sold, plan not stated
10,203
$713.73K
7.3%
LGND LIGAND PHARMACEUTICALS INC
24 Mar 2014
See Explanation of Responses
Sold, plan not stated
31,698
$2.22M
11.3%
LGND LIGAND PHARMACEUTICALS INC
24 Mar 2014
See Explanation of Responses
Sold, plan not stated
18,306
$1.28M
11.5%
PTN PALATIN TECHNOLOGIES INC
27 Feb 2014
10% owner
Sold, plan not stated
200,827
$218.90K
7.5%
PTN PALATIN TECHNOLOGIES INC
27 Feb 2014
10% owner
Sold, plan not stated
59,388
$64.73K
7.1%
PTN PALATIN TECHNOLOGIES INC
27 Feb 2014
10% owner
Sold, plan not stated
33,610
$36.63K
7.1%
PTN PALATIN TECHNOLOGIES INC
26 Feb 2014
10% owner
Sold, plan not stated
33,236
$36.87K
1.2%
PTN PALATIN TECHNOLOGIES INC
26 Feb 2014
10% owner
Sold, plan not stated
7,745
$8.59K
0.9%
PTN PALATIN TECHNOLOGIES INC
26 Feb 2014
10% owner
Sold, plan not stated
4,416
$4.90K
0.9%
PTN PALATIN TECHNOLOGIES INC
25 Feb 2014
10% owner
Sold, plan not stated
151,535
$169.66K
5.3%
PTN PALATIN TECHNOLOGIES INC
25 Feb 2014
10% owner
Sold, plan not stated
44,147
$49.43K
5.0%
PTN PALATIN TECHNOLOGIES INC
25 Feb 2014
10% owner
Sold, plan not stated
25,060
$28.06K
5.0%
PTN PALATIN TECHNOLOGIES INC
24 Feb 2014
10% owner
Sold, plan not stated
191,804
$222.84K
6.2%
PTN PALATIN TECHNOLOGIES INC
24 Feb 2014
10% owner
Sold, plan not stated
52,528
$61.03K
5.6%
PTN PALATIN TECHNOLOGIES INC
24 Feb 2014
10% owner
Sold, plan not stated
29,710
$34.52K
5.6%
LGND LIGAND PHARMACEUTICALS INC
20 Feb 2014
10% owner
Sold, plan not stated
112,369
$8.21M
6.3%
LGND LIGAND PHARMACEUTICALS INC
20 Feb 2014
10% owner
Sold, plan not stated
18,615
$1.36M
6.2%
LGND LIGAND PHARMACEUTICALS INC
20 Feb 2014
10% owner
Sold, plan not stated
10,557
$771.17K
6.2%
LGND LIGAND PHARMACEUTICALS INC
20 Feb 2014
10% owner
Sold, plan not stated
5,359
$391.46K
6.3%
LGND LIGAND PHARMACEUTICALS INC
19 Feb 2014
10% owner
Sold, plan not stated
57,370
$4.19M
3.1%
LGND LIGAND PHARMACEUTICALS INC
19 Feb 2014
10% owner
Sold, plan not stated
9,464
$691.19K
3.1%
LGND LIGAND PHARMACEUTICALS INC
19 Feb 2014
10% owner
Sold, plan not stated
5,395
$394.01K
3.1%
LGND LIGAND PHARMACEUTICALS INC
19 Feb 2014
10% owner
Sold, plan not stated
2,771
$202.38K
3.2%
PTN PALATIN TECHNOLOGIES INC
19 Feb 2014
10% owner
Sold, plan not stated
19,077
$21.22K
0.6%
PTN PALATIN TECHNOLOGIES INC
19 Feb 2014
10% owner
Sold, plan not stated
14,059
$15.64K
1.5%
PTN PALATIN TECHNOLOGIES INC
19 Feb 2014
10% owner
Sold, plan not stated
10,470
$11.64K
1.9%
LGND LIGAND PHARMACEUTICALS INC
18 Feb 2014
10% owner
Sold, plan not stated
153,751
$11.48M
7.7%
LGND LIGAND PHARMACEUTICALS INC
18 Feb 2014
10% owner
Sold, plan not stated
16,915
$1.26M
5.2%
LGND LIGAND PHARMACEUTICALS INC
18 Feb 2014
10% owner
Sold, plan not stated
16,331
$1.22M
8.6%
LGND LIGAND PHARMACEUTICALS INC
18 Feb 2014
10% owner
Sold, plan not stated
14,003
$1.05M
13.8%
PTN PALATIN TECHNOLOGIES INC
18 Feb 2014
10% owner
Sold, plan not stated
122,443
$144.24K
11.4%
PTN PALATIN TECHNOLOGIES INC
18 Feb 2014
10% owner
Sold, plan not stated
110,885
$130.62K
17.0%
PTN PALATIN TECHNOLOGIES INC
14 Feb 2014
10% owner
Sold, plan not stated
15,622
$18.14K
2.3%
PTN PALATIN TECHNOLOGIES INC
14 Feb 2014
10% owner
Sold, plan not stated
13,410
$15.57K
1.2%
LGND LIGAND PHARMACEUTICALS INC
27 Nov 2013
10% owner
Sold, plan not stated
319,005
$18.21M
75.9%
LGND LIGAND PHARMACEUTICALS INC
26 Nov 2013
10% owner
Sold, plan not stated
208,500
$12.00M
61.9%
RIGL RIGEL PHARMACEUTICALS INC
19 Nov 2013
10% owner
Sold, plan not stated
484,622
$1.28M
42.8%
LGND LIGAND PHARMACEUTICALS INC
23 Sep 2013
10% owner
Sold, plan not stated
359,023
$15.98M
54.8%
RIGL RIGEL PHARMACEUTICALS INC
7 Jun 2013
10% owner
Bought
32,700
$113.39K
2.3%
LGND LIGAND PHARMACEUTICALS INC
23 Jan 2013
10% owner
Bought
39,600
$783.18K
1.9%
LGND LIGAND PHARMACEUTICALS INC
14 Dec 2012
10% owner
Bought
5,386
$100.36K
0.3%
LGND LIGAND PHARMACEUTICALS INC
6 Dec 2012
10% owner
Bought
50,100
$898.96K
2.4%
GYRE GYRE THERAPEUTICS, INC.
16 Nov 2012
10% owner
Bought
73,500
$375.46K
2.9%
GYRE GYRE THERAPEUTICS, INC.
14 Nov 2012
10% owner
Bought
1,216,712
$4.87M
88.0%
GYRE GYRE THERAPEUTICS, INC.
8 Nov 2012
10% owner
Bought
49,329
$197.65K
2.8%
GYRE GYRE THERAPEUTICS, INC.
7 Nov 2012
10% owner
Bought
23,100
$94.28K
1.3%
GYRE GYRE THERAPEUTICS, INC.
2 Nov 2012
10% owner
Bought
57,600
$233.48K
3.3%
GYRE GYRE THERAPEUTICS, INC.
1 Nov 2012
10% owner
Bought
23,400
$94.69K
2.4%
GYRE GYRE THERAPEUTICS, INC.
1 Nov 2012
10% owner
Bought
6,700
$27.11K
0.4%
GYRE GYRE THERAPEUTICS, INC.
31 Oct 2012
10% owner
Bought
52,000
$210.90K
3.1%
LGND LIGAND PHARMACEUTICALS INC
31 Oct 2012
10% owner
Bought
4,076
$61.10K
0.6%
LGND LIGAND PHARMACEUTICALS INC
26 Oct 2012
10% owner
Bought
12,515
$190.93K
1.7%
LGND LIGAND PHARMACEUTICALS INC
21 Nov 2011
10% owner
Bought
340,200
$3.60M
19.7%
LGND LIGAND PHARMACEUTICALS INC
21 Nov 2011
10% owner
Bought
98,171
$1.04M
15.7%
LGND LIGAND PHARMACEUTICALS INC
18 Nov 2011
10% owner
Bought
72,669
$799.80K
4.2%
LGND LIGAND PHARMACEUTICALS INC
26 Oct 2011
10% owner
Bought
6,020
$83.75K
0.3%
LGND LIGAND PHARMACEUTICALS INC
21 Oct 2011
10% owner
Bought
4,600
$64.06K
0.3%
LGND LIGAND PHARMACEUTICALS INC
20 Oct 2011
10% owner
Bought
11,900
$165.81K
0.7%
LGND LIGAND PHARMACEUTICALS INC
18 Oct 2011
10% owner
Bought
2,200
$30.22K
0.1%
LGND LIGAND PHARMACEUTICALS INC
13 Oct 2011
10% owner
Bought
17,258
$233.88K
1.0%
LGND LIGAND PHARMACEUTICALS INC
13 Oct 2011
10% owner
Bought
4,995
$67.69K
0.8%
LGND LIGAND PHARMACEUTICALS INC
12 Oct 2011
10% owner
Bought
53,100
$726.99K
3.2%
NBIX NEUROCRINE BIOSCIENCES INC
12 Oct 2011
10% owner
Bought
29,500
$175.67K
0.8%
NBIX NEUROCRINE BIOSCIENCES INC
11 Oct 2011
10% owner
Bought
3,800
$21.77K
0.1%
NBIX NEUROCRINE BIOSCIENCES INC
10 Oct 2011
10% owner
Bought
44,700
$249.78K
1.3%
NBIX NEUROCRINE BIOSCIENCES INC
10 Oct 2011
10% owner
Bought
15,800
$88.29K
1.3%
NBIX NEUROCRINE BIOSCIENCES INC
10 Oct 2011
10% owner
Bought
9,600
$53.64K
1.3%
LGND LIGAND PHARMACEUTICALS INC
4 Oct 2011
10% owner
Bought
14,400
$183.96K
0.9%
CAPS Capstone Holding Corp.
6 Sep 2011
10% owner
Bought
312,900
$81.04K
7.3%
CAPS Capstone Holding Corp.
22 Aug 2011
10% owner
Bought
8,800
$2.29K
0.2%
LGND LIGAND PHARMACEUTICALS INC
19 Aug 2011
10% owner
Bought
21,300
$254.02K
1.3%
CAPS Capstone Holding Corp.
19 Aug 2011
10% owner
Bought
38,900
$10.11K
0.9%
LGND LIGAND PHARMACEUTICALS INC
18 Aug 2011
10% owner
Bought
16,571
$197.37K
1.0%
CAPS Capstone Holding Corp.
18 Aug 2011
10% owner
Bought
31,200
$8.11K
0.7%
LGND LIGAND PHARMACEUTICALS INC
11 Aug 2011
10% owner
Bought
1,394
$15.60K
0.1%
LGND LIGAND PHARMACEUTICALS INC
10 Aug 2011
10% owner
Bought
233,000
$2.54M
16.6%
LGND LIGAND PHARMACEUTICALS INC
9 Aug 2011
10% owner
Bought
133,000
$1.44M
9.8%
LGND LIGAND PHARMACEUTICALS INC
9 Aug 2011
10% owner
Bought
57,900
$629.03K
12.3%
LGND LIGAND PHARMACEUTICALS INC
8 Aug 2011
10% owner
Bought
175,800
$1.97M
14.9%
CAPS Capstone Holding Corp.
29 Jul 2011
10% owner
Bought
931,200
$232.80K
27.3%
CAPS Capstone Holding Corp.
28 Jul 2011
10% owner
Bought
23,050
$5.76K
0.6%
CAPS Capstone Holding Corp.
26 Jul 2011
10% owner
Bought
18,400
$4.60K
0.5%
CAPS Capstone Holding Corp.
20 Jul 2011
10% owner
Bought
252,600
$63.10K
7.3%
CAPS Capstone Holding Corp.
18 Jul 2011
10% owner
Bought
338,900
$84.42K
10.6%
CAPS Capstone Holding Corp.
14 Jul 2011
10% owner
Bought
19,700
$4.93K
0.6%
CAPS Capstone Holding Corp.
30 Jun 2011
10% owner
Bought
4,700
$1.17K
0.1%
CAPS Capstone Holding Corp.
29 Jun 2011
10% owner
Bought
12,950
$3.22K
0.4%
CAPS Capstone Holding Corp.
28 Jun 2011
10% owner
Bought
30,400
$7.60K
1.0%
CAPS Capstone Holding Corp.
27 Jun 2011
10% owner
Bought
56,700
$14.18K
1.8%
NBIX NEUROCRINE BIOSCIENCES INC
12 Apr 2010
10% owner
Sold, plan not stated
104,000
$291.40K
2.0%
NBIX NEUROCRINE BIOSCIENCES INC
9 Apr 2010
10% owner
Sold, plan not stated
94,000
$259.29K
1.8%
NBIX NEUROCRINE BIOSCIENCES INC
31 Mar 2010
10% owner
Sold, plan not stated
1,000
$2.70K
0.0%
NBIX NEUROCRINE BIOSCIENCES INC
30 Mar 2010
10% owner
Sold, plan not stated
104,000
$280.85K
1.9%
NBIX NEUROCRINE BIOSCIENCES INC
29 Mar 2010
10% owner
Sold, plan not stated
77,100
$208.35K
1.4%
NBIX NEUROCRINE BIOSCIENCES INC
26 Mar 2010
10% owner
Sold, plan not stated
31,200
$84.25K
0.6%
NBIX NEUROCRINE BIOSCIENCES INC
25 Mar 2010
10% owner
Sold, plan not stated
304,800
$822.96K
5.3%
NBIX NEUROCRINE BIOSCIENCES INC
24 Mar 2010
10% owner
Sold, plan not stated
88,000
$242.33K
1.5%
NBIX NEUROCRINE BIOSCIENCES INC
23 Mar 2010
10% owner
Sold, plan not stated
29,000
$79.75K
0.5%
NBIX NEUROCRINE BIOSCIENCES INC
22 Mar 2010
10% owner
Sold, plan not stated
72,000
$199.40K
1.2%
GYRE GYRE THERAPEUTICS, INC.
16 Oct 2009
10% owner
Sold, plan not stated
638,400
$15.06M
23.6%
LGND LIGAND PHARMACEUTICALS INC
24 Aug 2009
10% owner
Sold, plan not stated
4,552,550
$11.70M
30.0%
GYRE GYRE THERAPEUTICS, INC.
14 Jul 2009
10% owner
Bought
9,516
$28.49K
0.4%
GYRE GYRE THERAPEUTICS, INC.
13 Jul 2009
10% owner
Bought
2,200
$6.36K
0.1%
GYRE GYRE THERAPEUTICS, INC.
10 Jul 2009
10% owner
Bought
2,000
$5.58K
0.1%
GYRE GYRE THERAPEUTICS, INC.
9 Jul 2009
10% owner
Bought
21,500
$66.65K
0.8%
RGEN REPLIGEN CORP
7 Jul 2009
10% owner
Sold, plan not stated
1,000
$5.50K
0.0%
RGEN REPLIGEN CORP
6 Jul 2009
10% owner
Sold, plan not stated
450,800
$2.49M
14.0%
LGND LIGAND PHARMACEUTICALS INC
1 Jul 2009
10% owner
Sold, plan not stated
142,700
$423.63K
0.9%
LGND LIGAND PHARMACEUTICALS INC
29 Jun 2009
10% owner
Sold, plan not stated
58,616
$172.55K
0.4%
LGND LIGAND PHARMACEUTICALS INC
26 Jun 2009
10% owner
Sold, plan not stated
479,256
$1.40M
3.0%
LGND LIGAND PHARMACEUTICALS INC
25 Jun 2009
10% owner
Sold, plan not stated
291,393
$842.15K
1.8%
CRIS CURIS INC
27 Apr 2009
10% owner
Sold, plan not stated
2,970,000
$3.42M
33.3%
LGND LIGAND PHARMACEUTICALS INC
26 Jan 2009
10% owner
Bought
4,008
$8.02K
0.0%
LGND LIGAND PHARMACEUTICALS INC
23 Jan 2009
10% owner
Bought
39,728
$79.46K
0.2%
NBIX NEUROCRINE BIOSCIENCES INC
23 Jan 2009
10% owner
Bought
9,000
$27.88K
0.2%
NBIX NEUROCRINE BIOSCIENCES INC
22 Jan 2009
10% owner
Bought
6,900
$21.39K
0.1%
NBIX NEUROCRINE BIOSCIENCES INC
21 Jan 2009
10% owner
Bought
25,200
$77.10K
0.4%
NBIX NEUROCRINE BIOSCIENCES INC
20 Jan 2009
10% owner
Bought
75,000
$231.14K
1.3%
NBIX NEUROCRINE BIOSCIENCES INC
15 Jan 2009
10% owner
Bought
7,400
$22.59K
0.1%
NBIX NEUROCRINE BIOSCIENCES INC
30 Dec 2008
10% owner
Bought
10,600
$29.68K
0.2%
LGND LIGAND PHARMACEUTICALS INC
5 Dec 2008
10% owner
Bought
28,283
$56.07K
0.2%
LGND LIGAND PHARMACEUTICALS INC
4 Dec 2008
10% owner
Bought
96,300
$196.06K
0.7%
LGND LIGAND PHARMACEUTICALS INC
3 Dec 2008
10% owner
Bought
27,739
$54.08K
0.2%
LGND LIGAND PHARMACEUTICALS INC
2 Dec 2008
10% owner
Bought
193,000
$365.93K
1.5%
LGND LIGAND PHARMACEUTICALS INC
1 Dec 2008
10% owner
Bought
131,700
$245.48K
1.0%
NBIX NEUROCRINE BIOSCIENCES INC
1 Dec 2008
10% owner
Bought
99,400
$233.17K
1.7%
LGND LIGAND PHARMACEUTICALS INC
28 Nov 2008
10% owner
Bought
240,600
$479.61K
1.9%
LGND LIGAND PHARMACEUTICALS INC
26 Nov 2008
10% owner
Bought
1,350,000
$2.62M
11.8%
LGND LIGAND PHARMACEUTICALS INC
25 Nov 2008
10% owner
Bought
353,000
$625.48K
3.2%
LGND LIGAND PHARMACEUTICALS INC
24 Nov 2008
10% owner
Bought
143,000
$287.57K
1.3%
NBIX NEUROCRINE BIOSCIENCES INC
24 Nov 2008
10% owner
Bought
54,400
$133.26K
1.0%
LGND LIGAND PHARMACEUTICALS INC
21 Nov 2008
10% owner
Bought
186,744
$331.75K
1.7%
LGND LIGAND PHARMACEUTICALS INC
20 Nov 2008
10% owner
Bought
9,200
$11.63K
0.1%
LGND LIGAND PHARMACEUTICALS INC
19 Nov 2008
10% owner
Bought
33,000
$45.91K
0.3%
LGND LIGAND PHARMACEUTICALS INC
18 Nov 2008
10% owner
Bought
81,400
$112.54K
0.8%
LGND LIGAND PHARMACEUTICALS INC
17 Nov 2008
10% owner
Bought
92,000
$122.32K
0.9%
LGND LIGAND PHARMACEUTICALS INC
14 Nov 2008
10% owner
Bought
210,000
$273.05K
2.0%
LGND LIGAND PHARMACEUTICALS INC
13 Nov 2008
10% owner
Bought
94,000
$126.23K
0.9%
LGND LIGAND PHARMACEUTICALS INC
12 Nov 2008
10% owner
Bought
14,511
$19.57K
0.1%
LGND LIGAND PHARMACEUTICALS INC
11 Nov 2008
10% owner
Bought
167,850
$233.43K
1.7%
LGND LIGAND PHARMACEUTICALS INC
10 Nov 2008
10% owner
Bought
198,000
$270.07K
2.0%
LGND LIGAND PHARMACEUTICALS INC
7 Nov 2008
10% owner
Bought
113,000
$159.32K
1.2%
CAPS Capstone Holding Corp.
14 Oct 2008
10% owner
Bought
946,500
$598.08K
22.6%
CAPS Capstone Holding Corp.
13 Oct 2008
10% owner
Bought
2,600
$1.64K
0.1%
NBIX NEUROCRINE BIOSCIENCES INC
10 Oct 2008
10% owner
Bought
447,047
$1.22M
8.6%
CAPS Capstone Holding Corp.
10 Oct 2008
10% owner
Bought
237,500
$136.75K
6.0%
NBIX NEUROCRINE BIOSCIENCES INC
8 Jul 2008
10% owner
Bought
3,400
$14.45K
0.1%
NBIX NEUROCRINE BIOSCIENCES INC
7 Jul 2008
10% owner
Bought
115,700
$490.72K
2.3%
NBIX NEUROCRINE BIOSCIENCES INC
3 Jul 2008
10% owner
Bought
11,100
$46.03K
0.2%
NBIX NEUROCRINE BIOSCIENCES INC
2 Jul 2008
10% owner
Bought
26,600
$111.10K
0.5%
NBIX NEUROCRINE BIOSCIENCES INC
28 May 2008
10% owner
Bought
22,100
$104.31K
0.4%
NBIX NEUROCRINE BIOSCIENCES INC
27 May 2008
10% owner
Bought
5,000
$23.56K
0.1%
NBIX NEUROCRINE BIOSCIENCES INC
16 May 2008
10% owner
Bought
26,300
$122.36K
0.5%
NBIX NEUROCRINE BIOSCIENCES INC
15 May 2008
10% owner
Bought
126,300
$584.45K
2.6%
NBIX NEUROCRINE BIOSCIENCES INC
20 Mar 2008
10% owner
Bought
43,600
$218.00K
0.9%
NBIX NEUROCRINE BIOSCIENCES INC
18 Mar 2008
10% owner
Bought
153,000
$759.11K
3.3%
NBIX NEUROCRINE BIOSCIENCES INC
13 Mar 2008
10% owner
Bought
23,900
$117.53K
0.5%
NBIX NEUROCRINE BIOSCIENCES INC
12 Mar 2008
10% owner
Bought
14,800
$74.00K
0.3%
NBIX NEUROCRINE BIOSCIENCES INC
11 Mar 2008
10% owner
Bought
141,800
$694.27K
3.2%
NBIX NEUROCRINE BIOSCIENCES INC
10 Mar 2008
10% owner
Bought
225,000
$1.10M
5.3%
NBIX NEUROCRINE BIOSCIENCES INC
7 Mar 2008
10% owner
Bought
104,600
$521.91K
2.5%
NBIX NEUROCRINE BIOSCIENCES INC
6 Mar 2008
10% owner
Bought
86,700
$433.16K
2.1%
NBIX NEUROCRINE BIOSCIENCES INC
4 Mar 2008
10% owner
Bought
23,200
$115.42K
0.6%
NBIX NEUROCRINE BIOSCIENCES INC
3 Mar 2008
10% owner
Bought
98,000
$483.01K
2.5%
NBIX NEUROCRINE BIOSCIENCES INC
29 Feb 2008
10% owner
Bought
47,400
$236.71K
1.2%
NBIX NEUROCRINE BIOSCIENCES INC
28 Feb 2008
10% owner
Bought
23,000
$115.00K
0.6%
NBIX NEUROCRINE BIOSCIENCES INC
26 Feb 2008
10% owner
Bought
20,800
$103.98K
0.5%
NBIX NEUROCRINE BIOSCIENCES INC
25 Feb 2008
10% owner
Bought
108,000
$535.20K
3.2%
NBIX NEUROCRINE BIOSCIENCES INC
22 Feb 2008
10% owner
Bought
79,000
$382.31K
2.4%
NBIX NEUROCRINE BIOSCIENCES INC
21 Feb 2008
10% owner
Bought
106,000
$498.58K
3.3%
225 decisions on file.